Larissa T. Mooney, MD

Larissa Mooney, MD is a board certified addiction psychiatrist and Associate Clinical Professor of Psychiatry at the University of California, Los Angeles (UCLA). She is the Director of the UCLA Addiction Psychiatry Clinic and Chief of the Greater Los Angeles Veterans Affairs Substance Use Disorders Section, where she supervises psychiatrists in training in the clinical management of addictive and mental health disorders. Dr. Mooney is Past President of the American Academy of Addiction Psychiatry (AAAP), a Distinguished Fellow of the American Psychiatric Association (APA), and a Fellow of the American Association of Addiction Medicine (ASAM). Dr. Mooney has conducted research at UCLA Integrated Substance Abuse Programs on pharmacological and behavioral treatment interventions for addictive disorders. She is one of two PIs for the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network. She has current NIDA funding to study functional outcomes in cannabis users and treatment interventions for opioid use disorder and stimulant use disorder.

No Relevant Financial Disclosures

Overview

This 1-hour, live webinar will summarize recommendations on medication management for stimulant use disorder from ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. The webinar will include discussion of a case scenario and a question-and-answer session.

The target audience for this webinar series includes physicians, advanced practice providers (i.e., nurses, nurse practitioners, and physician assistants), and addiction educators.

This webinar series addresses the following ACGME Competencies: Patient Care, Medical Knowledge, Practice-Based Learning, and Improvement. 

Learning Objectives

1. Summarize the guideline’s recommendations regarding medication management for stimulant use disorder 

2. Identify the importance of monitoring and ongoing assessment of risks and benefits 

3. Apply knowledge of medication management for stimulant use disorders using a case scenario